Long-term follow-up of atypical membranoproliferative glomerulonephritis: Are steroids indicated?

Pediatric Nephrology

Volumn 21, Issue 2, 2006, Pages 194-200

  Fujita, Teruo ^a   Nozu, Kandai ^a   Iijima, Kazumoto ^b   Kamioka, Ichiro ^a   Yoshiya, Kunihiko ^c   Tanaka, Ryojiro ^d   Hamahira, Kiyoshi ^e   Nakanishi, Koichi ^f   Yoshikawa, Norishige ^f   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c Hara Genitourinary Hospital   (Japan)

^d KOBE CHILDREN S HOSPITAL   (Japan)

^e HIMEJI RED CROSS HOSPITAL   (Japan)

^f WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitors; Atypical membranoproliferative glomerulonephritis; Prognosis; Steroid therapy; Typical membranoproliferative glomerulonephritis

Indexed keywords

CORTICOSTEROID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; LISINOPRIL; METHYLPREDNISOLONE; PREDNISOLONE; SAIREI TO;

ADOLESCENT; ARTICLE; CHILD; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDICATION; DRUG RESPONSE; FEMALE; FOLLOW UP; HEMATURIA; HERBAL MEDICINE; HUMAN; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; LONGITUDINAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SCHOOL; STEROID THERAPY; URINALYSIS; URINARY TRACT DISEASE;

ADOLESCENT; BIOPSY; CHILD; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; MALE; STEROIDS; TIME FACTORS;

EID: 30944453569     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2074-7     Document Type: Article

References (33)

1. Habib R (1973) Classification of glomerulonephritis based on morphology. In: Kincaid-Smith P, Mathew TH, Becker EL (eds) Glomerulonephritis morphology, natural history, and treatment. John Wiley and Sons, New York, pp17-41
2. Strife CF, McAdams AJ, West CD (1982) Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions. Clin Nephrol 18:9-16 6749363
3. Watson AR, Poucell S, Thorner P, Arbus GS, Rance CP, Baumal R (1984) Membranoproliferative glomerulonephritis type I in children: Correlation of clinical features with pathologic subtypes. Am J Kidney Dis 4:141-146 6475944
4. Yoshikawa N, Yoshiara S, Yoshiya K, Matsuo T, Matsuyama S, Okada S (1988) Focal and diffuse membranoproliferative glomerulonephritis in children. Am J Nephrol 8:102-107 3293441
5. Hattori M, Yamaguchi H, Kawaguchi H, Kono M, Kubota R, Tsunoda Y, Takeda Y, Ito K (1990) Clinico-pathological study of children with membranoproliferative glomerulonephritis (MPGN) characterized by focal, segmental lesion (in Japanese). Jpn J Pediatr 94:2407-2416
6. Iitaka K, Nakamura S, Moriya S, Motoyama O, Sakai T (2003) Focal segmental membranoproliferative glomerulonephritis in children. Pediatr Nephrol 18:1000-1004 10.1007/s00467-003-1231-0
7. McAdams AJ, McEnery PT, West CD (1975) Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy. J Pediatr 86:23-31 1089142
8. McEnery PT, McAdams AJ, West CD (1980) Membranoproliferative glomerulonephritis: Improved survival with alternate day prednisone therapy. Clin Nephrol 13:117-124 7379361
9. Warady BA, Guggenheim SJ, Sedman A, Lum GM (1985) Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 107:702-707 3903090
10. Mota-Hernandez F, Gordillo-Paniagua G, Munoz-Arizpe R, Lopez-Arriaga JA, Barboza-Madueno L (1985) Prednisone versus placebo in membranoproliferative glomerulonephritis: Long-term clinicopathological correlations. Int J Pediatr Nephrol 6:25-28 3888886
11. Ford DM, Briscoe DM, Shanley PF, Lum GM (1992) Childhood membranoproliferative glomerulonephritis type I: Limited steroid therapy. Kidney Int 41:1606-1612 1501416
12. Yamazaki Y, Shimada M, Tateishi S, Shimizu T, Nomura Y (1997) Atypical Membranoproliferative glomerulonephritis (MPGN) in children - effect of methylprednisolone pulse therapy (MPT) (in Japanese). Jpn J Pediatr 101:819-824
13. International Study of Kidney Disease in Children (1982) Alternate-day steroid therapy in membranoproliferative glomerulonephritis: A randomized controlled clinical trial. Kidney Int 21:150
14. McEnery PT, McAdams AJ, West CD (1985) The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltimore) 64:401-424
15. Kawasaki Y, Suzuki J, Nozawa R, Suzuki H (2002) Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1. Arch Dis Child 86:21-25 10.1136/adc.86.1.21
16. Iitaka K, Ishidate T, Hojo M, Kuwao S, Kasai N, Sakai T (1995) Idiopathic membranoproliferative glomerulonephritis in Japanese children. Pediatr Nephrol 9:272-277 7632509
17. Hebert LA, Cosio FG, Neff JC (1991) Diagnostic significance of hypocomplementemia. Kidney Int 39:811-821 1829775
18. Matsell DG, Roy S III, Tamerius JD, Morrow PR, Kolb WP, Wyatt RJ (1991) Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. Am J Kidney Dis 17:311-316 1996575
19. Churg J, Bernsten J, Glassock RJ (1995) Renal disease, classification and atlas of glomerular disease. Igaku-Shoin, Tokyo, New York, pp 107-131
20. Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet 760:1299-1302 10.1016/S0140-6736(70)91905-7
21. Ginsberg JM, Chang BS, Matarese RA, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543-1546 6656849
22. Houser M (1984) Assessment of proteinuria using random urine samples. J Pediatr 104:845-848 6726514
23. Shaw AB, Risdon P, Lewis-Jackson JD (1983) Protein creatinine index and Albustix in assessment of proteinuria. Br Med J (Clin Res Ed) 287:929-932
24. McEnery PT (1990) Membranoproliferative glomerulonephritis: The Cincinnati experience - cumulative renal survival from 1957 to 1989. J Pediatr 116:109-114
25. Habib R, Levy M, Gubler MC (1976) Membranoproliferative glomerulonephritis: Morphological patterns, immunofluorescence and complement studies. Proceedings of the 11th Congress of the International Academy of Pathology, Washington DC, pp 106
26. Levy M, Gubler M, Habib R (1979) New concepts on membranoproliferative glomerulonephritis. In: Kincaid-Smith P, d'Apice AJF, Atkins RC (eds) Progress in glomerulonephritis. John Wiley and Sons, New York, pp 177-205
27. Kitagawa T (1988) Lessons learned from the Japanese nephritis screening study. Pediatr Nephrol 2:256-263 10.1007/BF00862602
28. Kincaid-Smith P (1972) The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function. Med J Aust 9:587-592
29. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibitor on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462 10.1056/ NEJM199311113292004
30. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359-364 10.1016/S0140-6736(98)10363-X
31. Russo D, Pisani A, Balletta MM, De Nicoli L, Savino FA, Andreucci M, Minutolo R (1999) Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 33:851-856 10213639
32. Gansevoort RT, de Zeeuw D, de Jong PE (1994) Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 45:861-867 8196289
33. Butani L (2003) Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade. Pediatr Nephrol 18:1199 10.1007/s00467-003-1296-9